(NASDAQ:SSKN), HORSHAM, Penn., Nov. 13, 2025 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended September 30, 2025, and provides a corporate update. Third Quarter […]

(NASDAQ:AIRJ), RONAN, Mont., Nov. 13, 2025 (GLOBE NEWSWIRE) — AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or “AIRJ”), a leading technology platform that unleashes the power of water from air, today announced its third quarter 2025 results and provided a business update highlighting progress toward near-term commercialization. “AirJoule Technologies is addressing emerging opportunities driven by

(TSX:URB),(TSX:URB-A),(TSX:URB.A),(CNSX:URB.CN),(CNSX:URB-A.CN),(CNSX:URB.A.CN),(CNSX:URB), NOT FOR DISTRIBUTION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Urbana Corporation (TSX & CSE: URB & URB.A) Urbana Corporation announces today that it has filed its unaudited interim Financial Statements and Management's Discussion and Analysis for the nine-month period ended September 30, 2025

(NASDAQ:PACB), MENLO PARK, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences: Wolfe Research Healthcare Conference 2025 in New York, NY Fireside chat on Tuesday, November 18 at 8:40 AM ET Jefferies

(NASDAQ:ATER), Produced Higher Margins, Lower Operating Expenses, and Significantly Narrowed Losses Compared to Q2 2025 New Product Introductions and Sales Channel Expansion Broadening Market Reach SUMMIT, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a consumer products company, today announced financial results for the third quarter ended September

(NASDAQ:ZSPC), SAN JOSE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — zSpace, Inc. (NASDAQ: ZSPC) (“zSpace” or the “Company”), a global leader in immersive augmented reality (AR) learning solutions for education, is announcing its financial results for the three and nine months ended September 30, 2025. “Our third quarter results reflect our focus on advancing our

(NASDAQ:JBIO), Presented favorable preclinical safety data for JADE101 and a translational analysis of APRIL mediated biomarker responses at the American Society of Nephrology Kidney Week 2025, reinforcing its potential as a best-in-class selective anti-APRIL monoclonal antibody for IgA nephropathy Initiated Phase 1 healthy volunteer study of JADE101; interim, biomarker-rich data expected in the first half

(NASDAQ:SPRO), Results from PIVOT-PO Phase 3 trial evaluating tebipenem HBr in complicated urinary tract infection (cUTI) presented as IDWeek late-breaker in October 2025 Spero's development partner, GSK, plans to submit data from the PIVOT-PO trial as part of a planned US Food and Drug Administration (FDA) filing in 4Q 2025 Company expects current cash and

(NASDAQ:CV), SARATOGA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results for its third quarter ended September 30, 2025. Recent Highlights Third quarter 2025 revenue was $3.5 million, a 19% increase over the third quarter of

(NASDAQ:TOI),(NASDAQ:TOIIW), CERRITOS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended September 30, 2025 and updated its full year 2025 guidance. Recent Operational Highlights Fee-for-service revenue